The most expensive study is one you have to repeat. 10 things to know before you start your GLP study.

Good laboratory practice (GLP) studies are an essential component to medical product development and regulatory submissions. They are highly rigorous, are conducted in compliance with a  legally bound code of federal regulations (21 CFR Part 58) and should be conducted by qualified scientists and staff of an accredited contract research organization (CRO). They are also…

How GCMI helps Georgia Tech faculty members convert research into innovative medical products – Our one-on-one interview with Dr. Omer Inan

GCMI’s foremost goal as an affiliate of the Georgia Institute of Technology is to partner with Georgia Tech faculty and engineers in the innovation process of new medical products. One successful example of this partnership has been our work with Dr. Scott Hollister. With GCMI’s help, Children’s Healthcare of Atlanta surgeons used Dr. Hollister’s process…

Is Getting New Treatments to Patients Harder Than Landing on Mars?

“Is Getting New Treatments to Patients Harder Than Landing on Mars?” Georgia Tech Research Horizons Senior Science Writer, Ben Brumfield, recently enlisted GCMI CEO, Tiffany Wilson, to help answer the question. According to the article, only 15% of new therapies make it to patients, and getting a new treatment to market can require $1 billion in pharmaceutical company investment, “more than the entire budget for the latest NASA Mars mission.” 

Join GCMI as we take a look into the future of spine therapy innovation at NASS 2019

The North American Spine Society (NASS) Annual Meeting is the gathering with arguably the greatest ability to influence the global market for spinal implants and devices, its innovation and growth. T3 Labs Orthopedic Program Director Dr. Evan Goldberg, a long-time veteran of this industry-leading spine conference, will be onsite at NASS 2019 in Chicago on September 25-28.